|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2009-5-20
|
|
pubmed:abstractText |
To determine whether the nuclear matrix protein-22 (NMP22) assay can improve the accuracy of discriminating between high-risk patients with and without bladder cancer.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1464-410X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1368-74
|
|
pubmed:dateRevised |
2010-3-10
|
|
pubmed:meshHeading |
pubmed-meshheading:19338566-Adolescent,
pubmed-meshheading:19338566-Adult,
pubmed-meshheading:19338566-Aged,
pubmed-meshheading:19338566-Aged, 80 and over,
pubmed-meshheading:19338566-Early Detection of Cancer,
pubmed-meshheading:19338566-Epidemiologic Methods,
pubmed-meshheading:19338566-Female,
pubmed-meshheading:19338566-Hematuria,
pubmed-meshheading:19338566-Humans,
pubmed-meshheading:19338566-Male,
pubmed-meshheading:19338566-Middle Aged,
pubmed-meshheading:19338566-Nomograms,
pubmed-meshheading:19338566-Nuclear Proteins,
pubmed-meshheading:19338566-Point-of-Care Systems,
pubmed-meshheading:19338566-Predictive Value of Tests,
pubmed-meshheading:19338566-Tumor Markers, Biological,
pubmed-meshheading:19338566-Urinary Bladder Neoplasms,
pubmed-meshheading:19338566-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.
|
|
pubmed:affiliation |
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
